Spns2-IN-3

• Description :

  Sphingolipid E is a synthetic pseudoceramide sphingolipid similar to type 2 ceramide with a metastable lamellar structure. Sphingolipid E ??can be used as a potential drug carrier to control the penetration of molecules as a lipid component of the intercellular space of the stratum corneum[1].

• UNSPSC :

  12352005

• Target :

  LPL Receptor

• Related Pathways :

  GPCR/G Protein

• Field of Research :

  Inflammation/Immunology

• Smiles :

  CC(C)C(N([C@@H]1CN(CC1)C2=NC(C=C(C(F)=C3)F)=C3N=C2C4=CC(OC(F)(F)F)=CC=C4)CCO)=O

• Molecular Formula :

  C25H25F5N4O3

• Molecular Weight :

  524.48

• References & Citations :

  [1]DICKSON John Kenneth, et al. Preparation of substituted quinoxalines and related compounds as inhibitors of SPNS2 and uses thereof. World Intellectual Property Organization, WO2024076610 A2 2024-04-11.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3035022-30-8]